Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4401
iShares MSCI Germany ETF
EWG
$1.62B
| $69.2K | ﹤0.01% |
1,676
+1,596
| +1,995% | +$68.2K |
2023 Q4
11 quarters
|
|
4402
Comstock
LODE
$127M
| $68.8K | ﹤0.01% |
29,670
+10,979
| +59% | +$36.2K |
2025 Q4
3 quarters
|
|
4403
Black Stone Minerals
BSM
$2.96B
| $68.8K | ﹤0.01% |
4,804
+3,315
| +223% | +$48.3K |
2024 Q1
10 quarters
|
|
4404
Westwood Holdings Group
WHG
$178M
| $68.6K | ﹤0.01% |
3,682
+1,765
| +92% | +$34K |
2024 Q3
8 quarters
|
|
4405
One Stop Systems
OSS
$126M
| $68.3K | ﹤0.01% |
7,828
-6,851
| -47% | -$80K |
2025 Q3
4 quarters
|
|
4406
Seaport Entertainment Group
SEG
$269M
| $68.2K | ﹤0.01% |
2,980
+1,760
| +144% | +$46K |
2024 Q3
8 quarters
|
|
4407
Innovator Equity Defined Protection ETF - 1 Yr August
ZAUG
$159M
| $67.8K | ﹤0.01% |
2,430
| – | – |
2024 Q3
8 quarters
|
|
4408
Century Casinos
CNTY
$17M
| $67.7K | ﹤0.01% |
64,465
-2,565
| -4% | -$3.09K |
2014 Q3
48 quarters
|
|
4409
Xerox Holdings Corp Warrants
XRXDW
$11.4M
| $67.4K | ﹤0.01% |
244,281
+1
| +0% | – |
2026 Q1
2 quarters
|
|
4410
Innovator Equity Defined Protection ETF - 1 Yr January
ZJAN
$106M
| $67K | ﹤0.01% |
+2,356
| New | +$66.5K |
2026 Q3
0 quarters
|
|
4411
ALX Oncology
ALXO
$160M
| $66.8K | ﹤0.01% |
48,046
+15,162
| +46% | +$29.3K |
2022 Q1
18 quarters
|
|
4412
NI Holdings
NODK
$309M
| $66.4K | ﹤0.01% |
4,450
+1,718
| +63% | +$26.4K |
2017 Q2
37 quarters
|
|
4413
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$4B
| $65.9K | ﹤0.01% |
2,733
| – | – |
2024 Q1
10 quarters
|
|
4414
SITE Centers
SITC
$36M
| $65.6K | ﹤0.01% |
19,469
+11,901
| +157% | +$41.3K |
2013 Q2
53 quarters
|
|
4415
KRONOS Worldwide
KRO
$966M
| $65.4K | ﹤0.01% |
8,555
+5,207
| +156% | +$39.2K |
2016 Q3
40 quarters
|
|
4416
Oramed Pharmaceuticals
ORMP
$171M
| $65.4K | ﹤0.01% |
14,010
+6,473
| +86% | +$29.3K |
2015 Q4
43 quarters
|
|
4417
Whitehawk Therapeutics
WHWK
$180M
| $65.1K | ﹤0.01% |
17,321
+10,888
| +169% | +$45.9K |
2026 Q1
2 quarters
|
|
4418
Q32 Bio
QTTB
$276M
| $64.8K | ﹤0.01% |
+7,841
| New | +$109K |
2026 Q3
0 quarters
|
|
4419
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.03B
| $64.7K | ﹤0.01% |
2,850
| – | – |
2025 Q4
3 quarters
|
|
4420
ACRES Commercial Realty
ACR
$171M
| $64.4K | ﹤0.01% |
5,819
+4,941
| +563% | +$74.4K |
2022 Q1
18 quarters
|
|
4421
Trilogy Metals
TMQ
$384M
| $64.2K | ﹤0.01% |
20,701
-616
| -3% | -$2.08K |
2025 Q4
3 quarters
|
|
4422
Union Bankshares
UNB
$114M
| $64.1K | ﹤0.01% |
2,789
-124
| -4% | -$2.98K |
2024 Q3
8 quarters
|
|
4423
J. Jill
JILL
$333M
| $63.9K | ﹤0.01% |
2,622
+1,770
| +208% | +$34.7K |
2023 Q1
14 quarters
|
|
4424
iShares Global Consumer Discretionary ETF
RXI
$252M
| $63.6K | ﹤0.01% |
344
| – | – |
2026 Q1
2 quarters
|
|
4425
Protara Therapeutics
TARA
$163M
| $63.6K | ﹤0.01% |
20,845
+2,238
| +12% | +$8.72K |
2024 Q4
7 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.